Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$115.13M+28.9%$105.82M+23.4%$89.85M+8.3%$90.66M+6.7%$89.3M+9.5%
$7.85M+15.0%$7.6M+40.3%$6.31M+31.2%$6.13M+25.8%$6.83M+21.0%
$78.03M+39.3%$69.79M+28.8%$57.56M+5.0%$55.61M+7.4%$56.01M+9.6%
$15.04M+4.9%$14.26M-6.4%$13.77M-7.9%$15M+1.0%$14.34M-3.6%
$40.1M+17.4%$38.16M-11.7%$32.86M+15.1%$36.99M+4.9%$34.17M+10.4%
34.8%-3.4pp36.1%-14.4pp36.6%+2.2pp40.8%-0.7pp38.3%+0.3pp
$0.82+10.8%$0.80-16.7%$0.69+6.2%$0.79-2.5%$0.74+4.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is National Health Investors's revenue?
National Health Investors (NHI) generated $401.5M in revenue over the trailing twelve months, up 17.1% year over year.
Is National Health Investors profitable?
National Health Investors reported $148.1M in net income over the trailing twelve months, a 36.9% net margin.
What is National Health Investors's earnings per share?
National Health Investors's diluted EPS over the trailing twelve months is $3.10.
Where does National Health Investors's income statement data come from?
Every line is extracted from National Health Investors's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.